- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02213393
Cater With Care Effect Study (CwC)
Effectiveness of Cater With Care Products in Reaching Recommendations for Protein Intake During and After Hospital Stay and in Improving Functional Status After Hospital Stay in Elderly Patients.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Rationale: About 25% of hospitalized elderly patients are at risk of undernutrition at admission. Many hospitals provide an energy and protein enriched diet, extra snacks, and oral nutritional supplements if needed. Still, a considerable part of these patients are unable to meet protein requirements and are still at risk of undernutrition at hospital discharge. This may impair recovery of illness, partly due to loss of muscle mass and physical performance. To improve protein intake, Cater with Care products have been developed: a selection of foods and drinks that are consumed often by elderly persons, but now enriched with protein up to 10 grams per portion. We hypothesize that these products help to reach protein requirements in elderly patients during and after hospital stay and thereby improve their health outcomes.
Objective: To study the effectiveness of supplementing a standard hospital and 12-week home menu with protein-enriched Cater with Care products in reaching a protein intake of 1,2-1,5 g/kg/day and in improving functional status after hospital stay in elderly patients.
Study design: Randomised Controlled Trial (RCT) with 2 intervention groups and two phases: a hospital phase including all admitted patients and a home phase with a selection of patients.
Study population: Patients of 65 years or over who are admitted to the departments of Geriatrics, Pulmonary Disease, or Internal Medicine of Hospital Gelderse Vallei.
Intervention: The control group receives the standard hospital menu for elderly at risk of undernutrition (energy and protein rich) and a variety of foods and drinks to be used as part of their home diet for 12 weeks after hospitalization. Foods and drinks for home use are non-enriched variants of Cater with Care products (e.g. normal fruit juice).
The intervention group receives Cater with Care protein-enriched foods and drinks during hospital stay (in addition to the standard hospital menu) and at home as part of their home diet for 12 weeks.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Gelderland
-
Ede, Gelderland, Holandia, 6716 RP
- Hospital Gelderse Vallei
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Hospital phase:
- admitted to the wards of Geriatric medicine, Pulmonary Medicine, or Internal Medicine in Hospital Gelderse Vallei
- aged 65 years or over
- being eligible for receiving a standard protein enriched menu based on hospital protocol
- Home phase:
- included in the hospital phase of the study
- consent to continue treatment and study participation after hospital discharge
Exclusion Criteria:
- Hospital phase:
- unwilling to give consent for gathering data from the medical record or meal service system
- unable to understand Dutch
- food allergies, food intolerances or other dietary restrictions that prevents the patient from receiving the standard protein enriched menu or Cater with Care products based on the judgement of a dietician and/or medical staff
- expected length of hospital stay less than 4 days
- renal insufficiency (eGFR < 30 ml/min)
- starting with tube feeding or total parenteral nutrition within 2 days of admission
- refeeding syndrome score > 0 based on hospital screening tool for refeeding risk
- delirium at admission
- receiving palliative care
- Home phase:
- going to a nursing home, rehabilitation centre or hospice after hospital discharge
- cognitive impairment or diagnosed with dementia
- legally incapacitated
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Protein enriched products
The intervention group receives protein enriched products (CwC products) in the hospital and receives these also after discharge during 12 weeks.
|
The intervention group receives CwC protein enriched products.
After discharge the intervention group receives CwC products delivered at home for 12 weeks.
Inne nazwy:
|
Aktywny komparator: Usual menu
The control group receives the usual protein and energy rich menu in the hospital and receives regular products, no protein enrichment, after discharge during 12 weeks.
|
The control group receives the usual menu, which is energy and protein rich in this elderly patient group.
After discharge the control group receives regular products, no protein enrichment, at home for 12 weeks.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change from Baseline Protein intake and Physical functioning at 6 months
Ramy czasowe: 6 months
|
This study has 2 primary outcomes: protein intake and physical functioning.
These will be assessed at baseline (0), and 2, 6, 12 and 24 weeks after hospital discharge.
|
6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change in muscle strength from baseline to 6 months.
Ramy czasowe: 6 months
|
Muscle strength (leg and hand grip) will be assessed at baseline (0), and 2, 6, 12 and 24 weeks after hospital discharge.
|
6 months
|
Change in nutritional status from baseline to 6 months.
Ramy czasowe: 6 months
|
Nutritional status (MNA and dietary intake) will be assessed at baseline (0), and 2, 6, 12 and 24 weeks after hospital discharge.
|
6 months
|
Change in Quality of Life from baseline to 6 months.
Ramy czasowe: 6 months.
|
Quality of Life will be assessed with the EuroQoL-5D-5L (at baseline, and 12 and 24 weeks after hospital discharge)
|
6 months.
|
Change in Activities of Daily Living from baseline to 6 months.
Ramy czasowe: 6 months
|
Activities of Daily Living (ADL) will be assessed by using the Barthel index (at baseline, and 2, 6, 12 and 24 weeks after hospital discharge).
|
6 months
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
BMI
Ramy czasowe: 6 months
|
BMI is calculated from weight and length measurements at baseline (0), 2, 6, 12, 24 weeks after hospital discharge.
|
6 months
|
Physical Activity
Ramy czasowe: 6 months
|
Physical Activity will be assessed by using the LAPAQ questionnaire.
|
6 months
|
Length of hospital stay
Ramy czasowe: 12 weeks
|
The length of hospital stay will be recorded to include in an economic evaluation.
|
12 weeks
|
Costs of hospital stay
Ramy czasowe: 12 weeks
|
After discharge from the hospital, the costs of hospital stay will be calculated to include in the economic evaluation.
|
12 weeks
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Nicole M de Roos, PhD, Wageningen University
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- NL48893.081.14
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Protein enriched products
-
Prof. Dr. med. Andreas F. H. PfeifferEuropean UnionZakończonyCukrzyca typu 2 | Stan przedcukrzycowyNiemcy
-
The University of Texas Health Science Center,...EurofinsZakończonyZębopochodna infekcja szyi głębokiej przestrzeniStany Zjednoczone
-
Nutricia ResearchZakończonyRak jelita grubego | Rak płucNorwegia, Holandia, Belgia, Litwa, Estonia, Polska, Portugalia
-
Lawson Health Research InstituteZakończony
-
St. Louis UniversityZakończonyPrzedwczesny poród noworodka | Mleko ludzkieStany Zjednoczone
-
University of AlbertaAspen Medical ProductsZakończony
-
Brigham and Women's HospitalZakończony
-
Lung Therapeutics, IncZakończonyIdiopatyczne włóknienie płucZjednoczone Królestwo
-
Ain Shams UniversityZakończonyBadania przesiewowe w kierunku raka wątrobowokomórkowego
-
GE HealthcareZakończonyChoroba tętnicy szyjnejStany Zjednoczone